Accolade ACCD

Accolade trades at 1.1x EV/NTM revenue on a $556.7M enterprise value. Revenue grew 5.7% year over year to $105.1M in the quarter ending November 2024, an annual run rate of $420.0M. Accolade reports a 44.2% gross margin.

ARR ($M)
420
Net Dollar Retention
--
ARR Growth
5.8%
EV / NTM Revenue
1.1x
Payback Period
EV / Run Rate
1.3x
Price & Key Metrics
Price Performance
Company Details
Share Price: 7.02
Last Filing Date: 2024-11-30
Fiscal Year End: 02-28
Last Filing: Form
Founding Year: 2007
IPO Year: 2020
Description
Accolade is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care.
Reporting Notes
Categories
Healthcare Services Healthtech B2B SaaS Enterprise Software
Valuation
Market Cap: 572.73
Enterprise Value: 556.654
EV / Revenue Run Rate: 1.3x
EV / NTM Revenue: 1.1x
EV / 2026 Revenue Estimates: 1.0x
EV / 2027 Revenue Estimates: 0.8x
EV / 2028 Revenue Estimates: 0.7x
Key Business Metrics
Net Dollar Retention: --
Customers: --
ARR: 420
ARR Growth %: 6%
ARR/Customer ($K): --
ARR/Employee ($K): 175
Revenue
Revenue Run Rate: 420
ARR: 420
2026 Revenue Estimates: 584
2027 Revenue Estimates: 655
2028 Revenue Estimates: 769
LTM Revenue: 446
Last Year Run Rate: 397
Growth
Revenue Growth: 6%
ARR Growth: 6%
Growth Persistence: 62%
2026 Revenue Growth Estimates: 13%
2027 Revenue Growth Estimates: 12%
2028 Revenue Growth Estimates: 17%
Financials
Quarterly
Calendar Year
Frequently Asked Questions

How fast is Accolade growing?

Accolade grew revenue 5.7% year over year, reaching $105.1M in the quarter ending November 2024.

What multiple does Accolade trade at?

Accolade trades at 1.1x EV/NTM revenue and 1.3x EV/run-rate, on an enterprise value of $556.7M.

Is Accolade profitable?

For Accolade, operating income was -$122.3M last quarter and LTM free cash flow margin is -2.9%.

What sector is Accolade in?

Public Comps classifies Accolade under Healthcare Services, Healthtech, B2B SaaS, and Enterprise Software.

Where does Public Comps get Accolade's data?

Figures come from Accolade's own SEC filings, normalised into a consistent quarterly format and refreshed after each earnings release.